Shanghai Pudong Kechuang Group

Shanghai Pudong Kechuang Group is a state-backed investment and technology-finance group based in Shanghai's Pudong New Area. The company is not a drug developer; instead, it operates as a science-and-technology investment, incubation, and financial services platform supporting hard-tech sectors including biopharma, integrated circuits, artificial intelligence, and advanced manufacturing. Its business model combines direct venture and PE investment, fund-of-funds and fund management, science-and-technology lending, guarantees, leasing, intellectual property ABS, and innovation space operations. Through subsidiaries such as Haiwang Capital, the group invests in and supports emerging technology companies rather than developing its own therapeutic pipeline.